Global Gastric Cancer Market - Industry Trends and Forecast to 2027
Global Gastric Cancer Market - Industry Trends and Forecast to 2027
Gastric Cancer Market By Type (Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Others), Stages (Stage I, Stage II, Stage III, Stage IV, Others), Diagnosis (Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Others), Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027
Market Analysis and Insights: Global Gastric Cancer Market
· Gastric cancer market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing with the healthy CAGR in the above-mentioned research forecast period. Rising prevalence of cancer related disorders worldwide and emerging markets are the factors responsible for the growth of this market.
· Growing cases of gastrointestinal reflux disease drives the gastric cancer market. Due to adoption of unhealthy lifestyle such as obesity & smoking, genetic modification/alteration in genes and family history with cancer also boost up the gastric cancer market growth obesity and stringent FDA guidelines for the drug approval of new drug may hamper the gastric cancer market.
Global Gastric Cancer Market Scope and Market Size
· On the basis of type, the gastric cancer market is segmented into adenocarcinoma, lymphoma, gastrointestinal stromal tumor, carcinoid tumor and others
· On the basis of stages, the gastric cancer market is segmented into stage I, stage II, stage III, stage IV and others
· On the basis of diagnosis, the gastric cancer market is segmented into endoscopy, biopsy, imaging tests, exploratory surgery and others
· On the basis of treatment, the gastric cancer market is segmented into surgery, radiation therapy, chemotherapy, targeted therapy, palliative care and others. Targeted treatment includes trastuzumab, ramucirumab, imatinib, sunitinib, regorafenib and other
· Route of administration segment of gastric cancer market is segmented into oral, parenteral and others.
· On the basis of end-users, the gastric cancer market is segmented into hospitals, specialty clinics and others
· On the basis of distribution channel, the gastric cancer market has also been segmented into hospital pharmacy, retail pharmacy, others
Key Development in the Market:
· In April 2014, Eli Lilly and Company received FDA approval for CYRAMZA (ramucirumab) for the advanced gastric or gastro-esophageal junction adenocarcinoma, as a single agent or in combination with paclitaxel, after prior fluoropyrimidine or platinum-containing chemotherapy. With this, the company has strengthened its brand image in the market.
Get the sample copy of Report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-gastric-cancer-market
Gastric Cancer Market Country Level Analysis
The countries covered in the gastric cancer market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, in Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
Competitive Landscape and Gastric Cancer Market Share Analysis
· Genetech Inc
· Pfizer Inc
· Mylan N.V
· Daiichi Sankyo Company Limited
· Samsung Bioepis
· Celltrion Inc
· Amgen Inc
· Novartis AG
· Eli Lilly and Company
· Sun Pharmaceutical Industries Ltd
· Teva Pharmaceutical Industries Ltd
· Hikma Pharmaceutical PLC
Get Full Access of Report@ https://www.databridgemarketresearch.com/reports/global-gastric-cancer-market
MAJOR TOC OF THE REPORT
Ø INTRODUCTION
Ø MARKET SEGMENTATION
Ø EXECUTIVE SUMMARY
Ø PREMIUM INSIGHTS
Ø MARKET OVERVIEW
Ø QUESTIONNAIRE
RELATED REPORTS
Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-gastric-cancer-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related Reports@
